On August 04, 2022, Histogen Inc. (NASDAQ: HSTO) opened at $3.00, higher 13.45% from the last session. During the day, the shares moved up to $3.85 and dropped to $2.63 before settling in for the closing price of $2.75. Price fluctuations for HSTO have ranged from $2.06 to $18.60 over the past 52 weeks.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 5.20%. Company’s average yearly earnings per share was noted 81.30% at the time writing. With a float of $38.33 million, this company’s outstanding shares have now reached $49.95 million.
Considering the fact that the conglomerate employs 22 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is +78.68, operating margin of -1497.77, and the pretax margin is -1454.36.
Histogen Inc. (HSTO) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Histogen Inc. is 5.86%, while institutional ownership is 8.00%.
Histogen Inc. (HSTO) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 3/30/2022, the company posted -$0.2 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$1.5) by $1.3. This company achieved a net margin of -1448.64 while generating a return on equity of -102.92. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.8 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 81.30% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 38.00% during the next five years compared to 50.50% growth over the previous five years of trading.
Histogen Inc. (NASDAQ: HSTO) Trading Performance Indicators
Check out the current performance indicators for Histogen Inc. (HSTO). In the past quarter, the stock posted a price to sales ratio for the trailing twelve months stands at 1.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.57, a number that is poised to hit -1.70 in the next quarter and is forecasted to reach -6.20 in one year’s time.
Technical Analysis of Histogen Inc. (HSTO)
Compared to the last year’s volume of 0.26 million, its volume of 0.85 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 25.19%. Additionally, its Average True Range was 0.43.
During the past 100 days, Histogen Inc.’s (HSTO) raw stochastic average was set at 14.50%, which indicates a significant decrease from 48.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 110.10% in the past 14 days, which was lower than the 155.34% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.74, while its 200-day Moving Average is $5.83. Nevertheless, the first resistance level for the watch stands at $3.77 in the near term. At $4.42, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.99. If the price goes on to break the first support level at $2.55, it is likely to go to the next support level at $1.98. Should the price break the second support level, the third support level stands at $1.33.
Histogen Inc. (NASDAQ: HSTO) Key Stats
There are currently 2,497K shares outstanding in the company with a market cap of 7.86 million. Presently, the company’s annual sales total 1,030 K according to its annual income of -14,950 K. Last quarter, the company’s sales amounted to 3,760 K and its income totaled -670 K.
